CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...